Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04610112
Other study ID # ABIntl-19-44
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 16, 2020
Est. completion date May 2025

Study information

Verified date January 2024
Source Advanced Bionics AG
Contact Arneborg Ernst, Prof. Dr.
Phone +49 (0) 30 56 81-4301
Email Arneborg.Ernst@ukb.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a prospective study designed to evaluate the safety and performance of the HiResTM Ultra Cl HiFocusTM MS Electrode and HiResTM Ultra 3D Cl HiFocusTM MS Electrode (Ultra X) under normal conditions of use as it is approved for this device.


Description:

This study is set up to document any adverse events and comparing pre- to post-implant benefit to subjects. Any adverse events associated with the device will be documented via Advanced Bionics complaint handling system for the lifetime of the device. A within-subjects repeated-measures design will be employed. Speech perception will be evaluated preoperatively with conventional amplification to determine candidacy and to establish baseline performance. Efficacy parameters are speech perception data which will be collected according to clinical routine with a 6 month follow up period. Subjects will be implanted unilaterally with the Ultra X according to standard clinical care. The primary efficacy objective is to demonstrate that mean monosyllabic word recognition score with the Ultra X used in combination with a sound processor programmed with the latest fitting software six months after activation is at least 20% better than the mean word score at baseline with conventional amplification in the same ear. The primary efficacy endpoint is reached six months after device activation.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date May 2025
Est. primary completion date May 2025
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - No previous experience with any auditory implant - 18 years of age or older - Postlingual onset of severe hearing loss (= 4 years of age) - Limited benefit from appropriately fitted hearing aids, defined as scoring 60% or less in Freiburger Monosyllabic word test - German language proficiency - Willingness to participate in all scheduled procedures outlined in the protocol Exclusion Criteria: - Cochlear malformation or obstruction that would preclude full insertion of electrode array. - Presence of additional disabilities that would prevent or interfere with participation in the required study procedures - Medical or psychological conditions that contraindicate surgery or impact the ability to manage an implanted device or the study related procedures - Evidence of central auditory lesion or compromised auditory nerve - Pregnancy at time of surgery.

Study Design


Intervention

Device:
cochlear implantation
patients receive a cochlear implantation within clinical routine

Locations

Country Name City State
Germany Unfallkrankenhaus Berlin (UKB Berlin
Germany Klinik für HNO-Heilkunde. Kopf- imd Halschirurgie Mannheim

Sponsors (1)

Lead Sponsor Collaborator
Advanced Bionics AG

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Other Device fitting data M-level [CU] CU=Clinical Units 6 months
Other Device verification data Impedances [Kilo Ohm] 6 months
Other Professional feedback from the audiologist using the latest fitting software to program the latest processor Feedback will be collected with a structured questionnaire 6 months
Other Feedback from the surgeon on handling of the device and tools during implantation Feedback will be collected with a structured questionnaire 6 months
Other Using habits of participants as summarized in the logging of the processor logging data in hours of usage logging of the processor and assessed in a patient questionnaire 6 months
Other Using habits of participants assessed in a patient questionnaire Assessement with a structured patient questionnaire 6 months
Primary Speech recognition score (word score) The primary efficacy objective is to demonstrate that mean monosyllabic word recognition score (Minimum Score 0 percent and maximum score 100 percent wheras 0 percent is worse and 100 is better) with the Ultra implants used in combination with a sound processor programmed with the latest fitting software is at least 20 percent better than the mean monosyllabic word score at baseline with conventional amplification in the same ear. 6 months
Primary Analysis of participants with device failure A maximum of one device failure that require device replacement during the first six months following device activation (activation approximately one to eight weeks after surgery). 6 months
Secondary Analysis of Speech reception threshold 50 percent speech reception threshold in the Oldenburger Sentence Test (OlSa) in noise in the implanted ear six months after device activation compared to baseline performance with conventional amplification in the same ear. 6 months
See also
  Status Clinical Trial Phase
Completed NCT03212924 - Listening Effort in Cochlear Implant Users N/A
Withdrawn NCT04041596 - Degree of Benefit From Low-Frequency Acoustic Amplification Using the Advanced Bionics Acoustic Earhook Phase 4
Completed NCT04610216 - Investigation of the Automatic Technology on the Naída M Hearing Devices
Completed NCT03288753 - Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors N/A
Completed NCT03248856 - Triamcinolone Levels in Cochlear Perilymph Phase 1
Completed NCT04048239 - Development of a Robotic Minimally Invasive Pathway for Cochlear Implantation N/A
Completed NCT04815343 - Investigation of the Naída CI M90 Sound Processor in Various Acoustic Scenarios N/A
Completed NCT04145661 - Non-linear Frequency Compared to Conventional Processing in Patients With and Without Cochlear Dead Regions. N/A
Recruiting NCT06114680 - Evaluation of the CochSyn Test Prototype to Measure Cochlear Synaptopathy N/A
Completed NCT03756337 - Neuro 1 vs. Neuro 2 Sound Processors N/A
Completed NCT04120181 - A New Predictor Marker for Cochlear Implants Infection
Terminated NCT05586555 - A Monocentric Study Evaluating Pupillometry as an Objective Measurement for CI Fittings N/A
Recruiting NCT04929470 - Safety and Performance of Ultra/Ultra 3D Cl With HiFocus SlimJ Electrode in Adults With Severe-to-profound Hearing Loss
Completed NCT04183348 - Evaluation of the Effect of a Visio-Hearing Training Protocol on Spatial Hearing in Subjects With Hearing Loss N/A
Not yet recruiting NCT06420921 - MeasurIng and Restoring Auditory Awareness for Cochlear Implant Listeners in noisE N/A
Completed NCT06235073 - Robotic and Manual Cochlear Implantation: An Intra-individual Study of Speech Recognition and Electrode Holder Position (ICRobMan)
Recruiting NCT05486637 - Vocal Emotion Communication With Cochlear Implants Early Phase 1
Recruiting NCT06301581 - Retrospective Analysis of Speech Performance Using the HiRes Ultra and HiRes Ultra 3D Cochlear Implant
Recruiting NCT06301568 - Retrospective Analysis of Long-term Speech Performance in Cochlear Implant Recipients Using Electro-acoustic Stimulation
Withdrawn NCT04651660 - Using Electrocochleography During Cochlear Implantation of the Neuro Zti. N/A